1.Real-world Cohort Study of Qingre Huoxue Prescription for Treating Rheumatoid Arthritis Complicated by Hyperhomocysteinemia
Ningyi WANG ; Quan JIANG ; Xun GONG ; Rouman ZHANG ; Tian CHANG ; Jiameng LIU
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(20):162-170
ObjectiveTo evaluate the effects of Qingre Huoxue prescription combined with methotrexate (MTX) and folic acid (FA) on homocysteine (Hcy) levels and disease activity in patients with rheumatoid arthritis (RA) complicated by hyperhomocysteinemia (HHcy). MethodsOn the basis of a multicenter real-world cohort from the China Registry of Traditional Chinese Medicine for Rheumatism (CERTAIN) platform,408 patients with RA complicated by HHcy were selected and included in this study. Treatment with Qingre Huoxue prescription was used as the exposure factor. According to whether Qingre Huoxue prescription was combined with MTX and FA,patients were assigned into an exposure group of 281 cases and a control group of 127 cases. Follow-ups were conducted every three months,with the primary outcome indicator being the achievement rate of target Hcy level. A generalized estimating equation model was adopted to analyze the dynamic changes in Hcy level under different medication regimens. Kaplan-Meier analysis was performed to evaluate the cumulative achievement rate of target Hcy level in the two groups,and Cox regression analysis was conducted to explore the predictive factors affecting the achievement rate of target Hcy level. Changes in erythrocyte sedimentation rate (ESR),C-reactive protein (CRP),28-joint disease activity score (DAS 28),and Health Assessment Questionnaire-Disability Index (HAQ-DI) scores before and after the first combined treatment with Qingre Huoxue prescription were compared between the two groups. ResultsThe Hcy level in the exposure group showed a gradual decreasing trend over time,while the decrease in Hcy level was not significant in the control group. At the 12-month follow-up,the achievement rate of target Hcy level in the exposure group (124/281,44.13%) was higher than that in the control group (23/127,18.11%,P<0.01). Multivariable Cox regression analysis showed that treatment with Qingre Huoxue prescription [hazard ratio(HR)=3.013,95% confidence interval (CI) 2.188-4.149, P<0.001], absence of comorbidities (HR=2.035, 95%CI 1.352-3.061, P<0.001), and baseline Hcy <15 μmol·L-1 (HR=1.810, 95%CI 1.390-2.357, P<0.001) were significantly associated with an increased likelihood of achieving target Hcy levels within 6 months. In contrast, higher PGA scores were associated with a reduced likelihood of achieving target Hcy levels (HR=0.991, 95% CI 0.986-0.997, P=0.003). After treatment,the exposure group demonstrated reductions in ESR,CRP,and DAS 28 scores (P<0.05) and had lower ESR,CRP and DAS 28 scores than the control group (P<0.05). ConclusionEven after taking FA supplements,some RA patients undergoing MTX treatment still have high Hcy levels. When being used in conjunction with MTX and FA,Qingre Huoxue prescription can effectively lower the Hcy level and disease activity in RA patients with HHcy,outperforming Western treatment alone.
2.Real-world Cohort Study of Qingre Huoxue Prescription for Treating Rheumatoid Arthritis Complicated by Hyperhomocysteinemia
Ningyi WANG ; Quan JIANG ; Xun GONG ; Rouman ZHANG ; Tian CHANG ; Jiameng LIU
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(20):162-170
ObjectiveTo evaluate the effects of Qingre Huoxue prescription combined with methotrexate (MTX) and folic acid (FA) on homocysteine (Hcy) levels and disease activity in patients with rheumatoid arthritis (RA) complicated by hyperhomocysteinemia (HHcy). MethodsOn the basis of a multicenter real-world cohort from the China Registry of Traditional Chinese Medicine for Rheumatism (CERTAIN) platform,408 patients with RA complicated by HHcy were selected and included in this study. Treatment with Qingre Huoxue prescription was used as the exposure factor. According to whether Qingre Huoxue prescription was combined with MTX and FA,patients were assigned into an exposure group of 281 cases and a control group of 127 cases. Follow-ups were conducted every three months,with the primary outcome indicator being the achievement rate of target Hcy level. A generalized estimating equation model was adopted to analyze the dynamic changes in Hcy level under different medication regimens. Kaplan-Meier analysis was performed to evaluate the cumulative achievement rate of target Hcy level in the two groups,and Cox regression analysis was conducted to explore the predictive factors affecting the achievement rate of target Hcy level. Changes in erythrocyte sedimentation rate (ESR),C-reactive protein (CRP),28-joint disease activity score (DAS 28),and Health Assessment Questionnaire-Disability Index (HAQ-DI) scores before and after the first combined treatment with Qingre Huoxue prescription were compared between the two groups. ResultsThe Hcy level in the exposure group showed a gradual decreasing trend over time,while the decrease in Hcy level was not significant in the control group. At the 12-month follow-up,the achievement rate of target Hcy level in the exposure group (124/281,44.13%) was higher than that in the control group (23/127,18.11%,P<0.01). Multivariable Cox regression analysis showed that treatment with Qingre Huoxue prescription [hazard ratio(HR)=3.013,95% confidence interval (CI) 2.188-4.149, P<0.001], absence of comorbidities (HR=2.035, 95%CI 1.352-3.061, P<0.001), and baseline Hcy <15 μmol·L-1 (HR=1.810, 95%CI 1.390-2.357, P<0.001) were significantly associated with an increased likelihood of achieving target Hcy levels within 6 months. In contrast, higher PGA scores were associated with a reduced likelihood of achieving target Hcy levels (HR=0.991, 95% CI 0.986-0.997, P=0.003). After treatment,the exposure group demonstrated reductions in ESR,CRP,and DAS 28 scores (P<0.05) and had lower ESR,CRP and DAS 28 scores than the control group (P<0.05). ConclusionEven after taking FA supplements,some RA patients undergoing MTX treatment still have high Hcy levels. When being used in conjunction with MTX and FA,Qingre Huoxue prescription can effectively lower the Hcy level and disease activity in RA patients with HHcy,outperforming Western treatment alone.
3.Premature Aging Prevention and Treatment Guided by Essence-Qi-Spirit Theory of Qiluo Doctrine: A Review
Chuanyuan JI ; Hongrong LI ; Jiameng HAO ; Dandong WANG ; Yucong MA ; Kun MA ; Cong WEI
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(2):279-285
The theoretical basis of premature aging originates from The Yellow Emperor's Inner Classic. The etiology of premature aging is complex, and the disease mechanism is based on deficiency. The treatment for premature aging is based on tonicity. The essence-Qi-spirit theory of Qiluo doctrine summarizes that "essence is the origin of life, Qi is the driving force of life, and spirit is the embodiment of life", which is the law of life. The theory puts forward the core disease mechanism of aging, which states that "deficiency of kidney essence is the root of aging, deficiency of primordial Qi is the key to aging, impairment of soma and spirit is the manifestation of aging". The theory also proposes the treatment of "tonifying kidney and supplementing essence, harmonizing Yin and Yang, warming and supporting primordial Qi, and nourishing soma and spirit" and the representative anti-aging drugs. The article unfolds from the perspective of the concepts of natural life span, premature senility before fifty, decline, and aging and also explains the origins and connotations of premature aging. The article explains the disease mechanism of premature aging under the guidance of the essence-Qi-spirit theory of Qiluo doctrine, which is "early deprivation of kidney essence, deficiency of primordial Qi, accumulation of deficiencies into impairment, and decline and impairment of soma and spirit", summarizes the progress of modern medical research on the treatment of premature aging and representative drugs, and finds that Bazi Bushen capsules have a precise therapeutic effect on the overall premature aging, systematic functional decline, and related diseases. The study provides theoretical basis and new ideas to solve the problems of premature aging and geriatric diseases.
4.Evaluating the effectiveness of surgical quality and safety improvement initiatives using interrupted time series analysis
Xiaoyu YANG ; Weiping WANG ; Hongtao WANG ; Yi LIU ; Jiameng ZHOU ; Zehua MA ; Xibei ZHOU ; Bo ZHANG
Modern Hospital 2025;25(7):1024-1026,1031
Objective To evaluate the impact of the"Surgical Quality and Safety Improvement Initiative"by analyzing changes in surgical quality and safety indicators at a tertiary hospital in Tianjin,and to provide policy recommendations for further enhancing surgical quality improvement pathways.Methods Surgical quality and safety monitoring data from 2022 to 2024 were collected from a tertiary hospital in Tianjin.Interrupted time series analysis(ITSA)was employed to assess the effects of im-provement measures on surgical quality and safety outcomes.Results Following implementation of the initiative,perioperative complication rates showed a declining trend(β3=-0.051,P<0.05),unplanned reoperation rates significantly decreased(β2=-0.121,P<0.05),and surgical mortality rates markedly declined(β2=-0.086,P<0.05),indicating that the man-agement measures effectively improved hospital surgical quality and safety over the study period.Conclusion The"Surgical Quality and Safety Improvement Initiative,"which established a comprehensive,staff-involved pathway for continuous surgical quality improvement,successfully enhanced surgical quality and safety.Recommendations include emphasizing frontline staff par-ticipation in quality management,strengthening data monitoring and feedback systems,implementing reasonable performance in-centives to motivate systemic improvement,and leveraging health information technology to support refined surgical management.
5.Analysis of gene detection results of next-generation sequencing of liquid based cytological specimens of lung adenocarcinoma cavity effusion and evaluation of clinical efficacy
Shuo LIANG ; Yuan WANG ; Zihan SUN ; Jiameng ZHANG ; Xiaoyue XIAO ; Cong WANG ; Yue SUN ; Xinxiang CHANG ; Linlin ZHAO ; Huan ZHAO ; Huiqin GUO ; Zhihui ZHANG
Chinese Journal of Oncology 2025;47(9):905-912
Objective:To analyze the results of next generation sequencing (NGS) gene testing in liquid-based cytological specimens of lung adenocarcinoma cavity and evaluate the clinical efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment.Methods:Liquid based cytological specimens of 222 cases of lung adenocarcinoma with cavity effusion and 201 cases of metastatic lymph node biopsy were collected. Specimens were obtained from the Cytology Laboratory of the Cancer Hospital of the Chinese Academy of Medical Sciences. The collection period was from January 2018 to December 2022. The results of NGS gene detection were compared. The clinical efficacy of 91 patients treated with EGFR-TKI was evaluated, and the survival curve was analyzed by Kaplan-Meier and other statistical methods.Results:The mutation rates of cancer-related genes detected by NGS were 82.0% (182/222) vs 79.1% (159/201), ( P=0.455) in liquid-based cytological specimens and histological specimens of metastatic lymph node biopsy, respectively. However, the mutation rate of EGFR T790M was significantly higher in cavity effusion than in lymph node biopsy specimens [12.2%(27/222)>3.5%(7/201), P=0.001]. The results of gene mutation were identical in 10 of the 13 cases with cavity effusion and metastatic lymph node biopsy, and the agreement rate of EGFR was 84.6%(11/13). In 3 inconsistent cases, EGFR mutations were detected in 2 cavity effusion cases that were not detected by lymph node biopsy. Results of genetic analysis of fluid-based cytological samples of 91 patients with cavity effusion were evaluated after drug treatment with EGFR-TKI. The mean progression-free survival (PFS) of the patients was 11.4 months (95% CI: 9.9-12.9). The mean PFS of patients harboring EGFR mutation was 12.3 months (95% CI: 10.8-13.9), and the mean PFS of EGFR wild type was 4.1 months (95% CI: 2.1-6.2). Conclusions:The results of NGS gene detection in liquid-based cytological specimens of lung adenocarcinoma patients with cavity effusion show that the PFS time is similar to that of histological specimens after clinical treatment with EGFR-TKI, which proves the reliability of NGS gene detection results in liquid cytological specimens. NGS gene testing appears higher sensitivity in cavity liquid-based samples than in metastatic lymph node samples.
6.Age,blood eosinophils,FeNO and serum IgE as biomarkers for the prediction of eosinophilic phenotype among asthmatic patients
Jiameng GAO ; Yuan MA ; Yao SHEN ; Fang WANG ; Yuhao QIAN ; Zhihong CHEN
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(5):631-639
AIM:To identify surrogate clinical bio-markers for profiling the eosinophilic status of an individual patient over induced sputum analysis.METHODS:We conducted a cross-sectional study on 100 asthmatic patients whose induced sputum was successfully collected.Subjects were further classified into either EA or NEA based on whether the percentage of sputum eosinophil count(SEC%)was≥3%.Demographic and clinical data were col-lected,including basic information,routine blood tests,lung function tests,bronchodilator reversibili-ty tests,fractional exhaled nitric oxide(FeNO),the Asthma Control Test(ACT)and the Asthma Control Questionnaire(ACQ).All variables significantly asso-ciated with EA were candidates for multivariate lo-gistic regression analysis.A scoring system present-ed as a nomogram for the prediction of EA was de-veloped.RESULTS:In the univariate analysis,com-pared with NEA subjects,those with EA were of older age and had worse asthma control and lung function in addition to higher values of blood eosin-ophils,serum IgE and FeNO.Multivariable logistic regression analysis revealed that age,FeNOx serum IgE and blood eosinophil count(BEC)were identi-fied as independent risk factors for eosinophilic asthma,which were all included in the nomogram.CONCLUSION:A combination assessment including age,FeNOx serum IgE and BEC could be applicable to clinicians in identifying eosinophilic asthma and is easier,faster,more inexpensive and more readily available than the induced sputum test.
7.Development of postoperative precision nursing program for children with obstructive sleep apnea-hypopnea syndrome
Yuli HU ; Jingqi BAI ; Huijuan QIAN ; Kaiming SU ; Jiameng CHEN ; Jie YUAN ; Chunsheng WANG ; Jiaxin YANG ; Ye ZHANG ; Siqiong JIANG
Modern Clinical Nursing 2025;24(5):41-48
Objective To develop a postoperative precision nursing program for children with obstructive sleep apnea-hypopnea syndrome(OSAHS),so as to provide references for the improvement of nursing quality for children with OSAHS.Methods Literature in precision nursing for children with OSAHS was systematically reviewed and summarised based on precision nursing theory and a postoperative precision nursing program was drafted.Using the Delphi's Method,two rounds of expert consultation were conducted and the postoperative precision nursing program for children with OSAHS was revised and finalised.Results The response rates of the two rounds of expert consultation were 100.00%with the expert authority coefficient of 0.875.The Kendall coefficient of concordance(W)of levels 1,2 and 3 indices in the second round of expert consultation were 0.289,0.203,0.187,respectively(all P<0.01).The importance score of each inclicator ranged from 4.50~4.94.The coefficient of variations for the three-level indices ranged from 0.05 to 0.21.The finalised program composed 8 level-1 indices(postoperative position assessment,intervention,prevention and care of bleeding,maintaining postoperative airway patency,postoperative nausea and vomiting care,postoperative pain assessment and care,dietary care,complication prevention and care,discharge guidance),16 level-2 indices,and 22 level-3 indices.Conclusion The postoperative precision nursing program for the children with OSAHS is scientific,innovative and applicable.It provides clinical references for nursing of the children with OSAHS.
8.Analysis of the composition of pediatric inpatient diseases in a certain second-class public hospital from 2019 to 2023
Yang LONG ; Yufeng WANG ; Huanping LONG ; Bo WANG ; Jiameng LI ; Tingting LONG
Modern Hospital 2025;25(9):1448-1452
Objective To analyze the disease composition of pediatric inpatients in a specific hospital and provide a sci-entific basis for the prevention,treatment,and rational allocation of medical resources within the jurisdiction.Methods Diagno-sis and treatment information of pediatric inpatients from January 1,2019,to May 31,2023,was collected via the hospital's medical record quality control system.A retrospective analysis was conducted on the disease composition and its changes among inpatients.Results The pediatric department of the hospital treated a total of 4 939 children,involving 16 categories and 83 types of diseases.Among them,the top three categories of diseases in terms of composition,from high to low,were respiratory system diseases,digestive system diseases,and oral diseases.From 2019 to 2022 and from January to May 2023,the top three categories of diseases in terms of composition,from high to low,were consistently:respiratory system diseases,digestive system diseases,and oral diseases.In the period from January to May 2023,the composition of respiratory system diseases decreased by 8.09%compared to 2019-2022;the composition of digestive system diseases increased by 8.00%compared to 2019-2022;and the composition of oral diseases decreased by 0.13%compared to 2019-2022.Conclusion Respiratory and digestive system diseases,as well as oral diseases,are critical areas for pediatric disease prevention and treatment within this jurisdiction.It is recommended that local health administrative departments optimize the allocation of medical resources,enhance preventive meas-ures,diagnosis,and treatment,and establish a robust health defense system for children in the region.
9.Distribution characteristics and influencing factors of ultra-long hospitalization in patients with malig-nant tumors
Xiaoyu YANG ; Weiping WANG ; Hongtao WANG ; Yi LIU ; Jiameng ZHOU ; Zehua MA ; Xibei ZHOU ; Bo ZHANG ; Jinpo ZHENG
Modern Hospital 2025;25(8):1223-1226
Objective To analyze the distribution characteristics and influencing factors of ultra-long hospitalization in malignant tumor patients and to explore strategies to reduce the average length of stay and enhance the efficiency of medical re-source utilization.Methods Ultra-long hospitalization was defined as the 99th percentile of hospital stay duration(P99=31 days).Data from patients discharged with malignant tumors in a specialized cancer hospital in 2024 were collected.The distribu-tion characteristics and influencing factors were analyzed using chi-square tests and logistic stepwise regression.Results Among the 36 097 patients with malignant tumors,the average length of stay was 4.95 days,with 375 cases classified as ultra-long hospi-talizations,accounting for 1.04%.These patients were predominantly over 55 years old,with a higher proportion of males.Pa-tients with stage Ⅲ malignant tumors,primary tumors classified as T2~T3,and primary sites in the esophagus,pancreas,and maxillofacial regions had a higher incidence of ultra-long hospitalizations.Significant factors influencing ultra-long hospitalization included treatment modality,complications(OR=20.319),number of discharge diagnoses(OR=6.915),ICU transfers(OR=4.714),unplanned reoperations(OR=4.416),tumor type,extent,and stage.Conclusion Medical institutions are advised to address the influencing factors of ultra-long hospitalizations by optimizing diagnostic and treatment processes,enhan-cing quality control systems,establishing early warning mechanisms,and strengthening information systems.These measures aim to improve the standardization of malignant tumor diagnosis and treatment,ensuring patient safety.
10.Regulatory role and mechanism of mitochondrial ribosomal protein S35 in proliferation,invasion,and migration of colon cancer cells
Jiameng ZHU ; Longhe SUN ; Qiannan SUN ; Jun REN ; Bin LIU ; Liuhua WANG ; Daorong WANG
Journal of Clinical Medicine in Practice 2025;29(2):24-31,37
Objective To investigate the regulatory role and mechanism of mitochondrial riboso-mal protein S35(MRPS35)in the proliferation,invasion,and migration of colon cancer cells.Meth-ods A total of 120 colon cancer tissues and adjacent normal tissues from patients undergoing radical resection for colon cancer were collected.Human colon cancer cell lines(HCT116,SW480,SW620)and a human normal colon epithelial cell line(NCM460)were cultured.Bioinformatics analysis,real-time quantitative polymerase chain reaction,Western blot,immunohistochemical(IHC)analysis,and cellular functional experiments(plate clone formation assay,scratch test,Transwell migration assay,CCK-8 cell viability assay)were conducted to evaluate the expression and regulatory mechanism of MRPS35 in colon cancer.Results Bioinformatics analysis showed that the expression level of the MRPS35 gene was higher in colorectal cancer tissues than in adjacent normal tissues(P<0.05).The relative expression levels of MRPS35 mRNA and MRPS35 protein were higher in human colon cancer cell lines(HCT116,SW480,SW620)than in NCM460 cells(P<0.05).The relative ex-pression level of MRPS35 protein was higher in colon cancer tissues than that in adjacent normal tis-sues(P<0.05).The expression level of MRPS35 was significantly correlated with tumor diameter,tumor differentiation,and T stage(P=0.002,0.021,0.036).Patients with high MRPS35 expres-sion had a higher overall survival rate than those with low MRPS35 expression(Log-rank P=0.015).After knockdown of MRPS35,the abilities of colon cancer cell cloning,proliferation,invasion,and migration were significantly enhanced.Furthermore,the expression of Wnt1,β-Catenin,and their downstream target proteins increased significantly after MRPS35 knockdown.Conclusion MRPS35 is significantly overexpressed in both colon cancer tissues and colon cancer cells,and it may inhibit the occurrence and development of colon cancer by regulating the Wnt/β-Catenin signaling pathway.Therefore,MRPS35 has the potential to become a novel biomarker and therapeutic target for colon cancer.

Result Analysis
Print
Save
E-mail